ロード中...
Phase II study of docetaxel in patients with relapsed or refractory malignant lymphoma
We report the activity and toxicity of docetaxel in 12 evaluable heavily pretreated patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. In all, 42% achieved a partial response, 25% achieved stable disease. Median duration of response was 16 (10–21) weeks. Th...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2741047/ https://ncbi.nlm.nih.gov/pubmed/12778057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600914 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|